MEI Pharma Secures Over $100 Million Funding Commitment to Launch Litecoin Treasury Strategy
BlockBeats News, July 19th, Titan Partners Group and crypto investment firm GSR are co-leading a strategic transformation of the US pharmaceutical company MEI Pharma (NASDAQ: MEIP), driving the establishment of a dedicated Litecoin treasury strategy. Currently, there has been over $100 million in funding commitments to this project.
It is worth mentioning that Litecoin creator Charlie Lee has agreed to join the MEI Pharma board of directors. Furthermore, the Litecoin Foundation has also invested in MEI Pharma as the company's treasury strategy aligns closely with the Litecoin Foundation's core mission of promoting global Litecoin adoption.
También te puede interesar
Ganadores
Últimas noticias sobre criptomonedas
Tom Lee: S&P 500 to Rise to 7300, Surge in Market Liquidity Could Be Explosive
Franklin Templeton XRP Spot ETF AUM Surpasses $100 Million
「ZEC&MON Top Short in History」 Take-Profit Section: The ZEC short position has made a profit of over $5 million, while simultaneously shorting MON has a unrealized gain of nearly $2 million.
Franklin Crypto Index ETF Adds ADA and 6 Other Tokens
Web3 robotics company XMAQUINA has announced the completion of a new funding round, led by Borderless.
Atención al cliente:@weikecs
Cooperación empresarial:@weikecs
Trading cuantitativo y MM:[email protected]
Programa VIP:[email protected]